Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.42 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
| ▸ | XPNPEP1 | Q9NQW7 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | FABP7 | O15540 | 2/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 3/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784932 | 1.00 | FABP5 (0.42) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL4249347 | 1.00 | FABP5 (0.42) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL3783541 | 1.00 | FABP5 (0.42) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL3789868 | 1.00 | FABP5 (0.42) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL2209916 | 0.89 | DPP8 (0.39) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL2209913 | 0.89 | DPP8 (0.39) | FABP5PEPDXPNPEP1KMT2AFABP7 | |
| SCHEMBL30861822 | 0.88 | FABP5 (0.46) | FABP5KMT2AFABP7EPHX2CASP3 | |
| SCHEMBL21895946 | 0.88 | FABP5 (0.46) | FABP5KMT2AFABP7EPHX2CASP3 | |
| SCHEMBL29855006 | 0.88 | FABP5 (0.46) | FABP5KMT2AFABP7EPHX2CASP3 | |
| SCHEMBL30278686 | 0.88 | FABP5 (0.46) | FABP5KMT2AFABP7EPHX2CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100174096-A1 | Methods for Production of Optically Active Fluoropyrrolidine Derivatives | IM&T RESEARCH, INC. (US) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174096-A1 | Methods for Production of Optically Active Fluoropyrrolidine Derivatives | QDPR, FDPS, DPYD | FABP5 1284/4885PEPD 190/4885XPNPEP1 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.